Evolution of 2- to 5-Year Prediagnosis Prostate-Specific Antigen (PSA) Testing According to Age Group and Stage at Diagnosis, Compared With Men Without Prostate Cancer (PCa). This evidence concerns the gene KLK3 and prostate cancer.